Premium
Cost of complications for patients with non‐infectious non‐anterior uveitis
Author(s) -
TUNDIA N,
SKUP M,
OYE B,
OKALIBE X,
CHAO J,
BAO Y,
DICK A
Publication year - 2014
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.2014.f076.x
Subject(s) - medicine , complication , glaucoma , anterior uveitis , ophthalmology , cataracts , surgery , uveitis
Purpose To estimate costs associated with eye‐related complications in non‐anterior non‐infectious uveitis (NIU). Methods Cases were ≥18 years old, had ≥2 diagnoses for non‐anterior (intermediate, posterior, or pan) NIU (Truven Health, 1/1/2000−12/31/2010), and developed complications (glaucoma, cataracts, visual disturbance, blindness, retinal detachment, cystoid macular degeneration). Cases and controls (NIU patients without complications) were matched 1:1 by uveitis type, sex, age, region, index date, and enrollment and followed for 1 year post complication. Annual mean total costs differences (medical and drugs) post complication were compared (ANCOVA). Results Annual total cost difference for any complication was significantly greater in patients with non‐anterior‐NIU overall ($7,596, N=1,327), posterior‐NIU (N=1,246, $7,117), and pan‐NIU ($24,595, N=27) vs controls (all P<.05); medical costs contributed more than drug costs. Annual mean total costs for visual disturbances, cataracts, and glaucoma combined were greater for non‐anterior‐NIU overall, posterior‐NIU, and pan‐NIU vs controls by $23,915, $23,182, and $50,213, respectively. Overall, the 1‐year post‐complication total cost burden was greater by $10,079,892 in non‐anterior NIU patients who developed complications vs controls. Conclusion This medical claims analysis revealed a significant economic burden due to complications of non‐anterior NIU.Commercial interest